• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质代谢的肾上腺素能控制

Adrenergic control of lipid metabolism.

作者信息

Smith U

出版信息

Acta Med Scand Suppl. 1983;672:41-4. doi: 10.1111/j.0954-6820.1983.tb01612.x.

DOI:10.1111/j.0954-6820.1983.tb01612.x
PMID:6138932
Abstract

Adrenergic receptors are ubiquitous and mediate several important effects involving lipid metabolism. Thus, beta-adrenergic stimulation increases lipolysis and inhibits the activity of the lipoprotein lipase. In contrast, alpha-adrenergic stimulation inhibits fat cell lipid mobilisation. Unexpectedly, beta-adrenergic blockade increases plasma triglyceride levels and tends to lower the high density lipoprotein (HDL-cholesterol). These effects seem to be prevented or attenuated by concomitant alpha-blockade. Possible mechanisms for the adrenergic effect on lipid metabolism are reviewed.

摘要

肾上腺素能受体广泛存在,并介导涉及脂质代谢的多种重要作用。因此,β-肾上腺素能刺激可增加脂肪分解并抑制脂蛋白脂肪酶的活性。相比之下,α-肾上腺素能刺激可抑制脂肪细胞的脂质动员。出乎意料的是,β-肾上腺素能阻断会增加血浆甘油三酯水平,并倾向于降低高密度脂蛋白(HDL-胆固醇)。这些作用似乎可通过同时进行的α-阻断来预防或减弱。本文综述了肾上腺素能对脂质代谢作用的可能机制。

相似文献

1
Adrenergic control of lipid metabolism.脂质代谢的肾上腺素能控制
Acta Med Scand Suppl. 1983;672:41-4. doi: 10.1111/j.0954-6820.1983.tb01612.x.
2
Effects of alpha-adrenergic and beta-adrenergic receptor blockade on lipid metabolism.α-肾上腺素能和β-肾上腺素能受体阻断对脂质代谢的影响。
Am J Med. 1986 Feb 14;80(2A):104-8. doi: 10.1016/0002-9343(86)90168-3.
3
The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat.α和β肾上腺素能受体亚型在介导儿茶酚胺对大鼠空腹血糖和胰岛素浓度影响中的作用。
Br J Pharmacol. 1990 Aug;100(4):699-704. doi: 10.1111/j.1476-5381.1990.tb14078.x.
4
Lipoteichoic acid stimulates lipolysis and hepatic triglyceride secretion in rats in vivo.脂磷壁酸在体内刺激大鼠的脂肪分解和肝脏甘油三酯分泌。
J Lipid Res. 1995 Sep;36(9):1987-95.
5
Regulation of lipolysis and lipoprotein lipase after weight loss in obese, postmenopausal women.肥胖绝经后女性体重减轻后脂解作用及脂蛋白脂肪酶的调节
Obes Res. 2004 Jan;12(1):32-9. doi: 10.1038/oby.2004.6.
6
Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.犬脂肪组织中的β3肾上腺素能受体:关于其在儿茶酚胺脂肪动员作用中所起作用的研究。
J Pharmacol Exp Ther. 1993 Jul;266(1):358-66.
7
Regulation of liver lipase. II. Involvement of the alpha 1-receptor.
Biochim Biophys Acta. 1984 Oct 4;795(3):481-6. doi: 10.1016/0005-2760(84)90176-0.
8
Mechanisms of action of adrenergic receptor blockers on lipids during antihypertensive drug treatment.抗高血压药物治疗期间肾上腺素能受体阻滞剂对血脂的作用机制。
J Clin Pharmacol. 1993 Mar;33(3):286-91. doi: 10.1002/j.1552-4604.1993.tb03958.x.
9
Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action.
Am J Med. 1986 Feb 14;80(2A):71-81. doi: 10.1016/0002-9343(86)90163-4.
10
The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
Artery. 1990;17(2):60-70.

引用本文的文献

1
Protective Effect of Carvedilol Against Oxidative Stress Induced by Palmitic Acid in Primary Rat Hepatocytes.卡维地洛对棕榈酸诱导的原代大鼠肝细胞氧化应激的保护作用。
Cell Biochem Funct. 2025 Feb;43(2):e70057. doi: 10.1002/cbf.70057.
2
Chromogranin A and its derived peptides: potential regulators of cholesterol homeostasis.嗜铬粒蛋白 A 及其衍生肽:胆固醇动态平衡的潜在调节剂。
Cell Mol Life Sci. 2023 Aug 29;80(9):271. doi: 10.1007/s00018-023-04908-3.
3
Challenges in Pharmacological Intervention in Perilipins (PLINs) to Modulate Lipid Droplet Dynamics in Obesity and Cancer.
干预 perilipins(PLINs)以调节肥胖和癌症中脂滴动态的药理学挑战。
Cancers (Basel). 2023 Aug 7;15(15):4013. doi: 10.3390/cancers15154013.
4
Influence of b2 adrenergic receptor polymorphism (rs1042713 and rs1042714) on anthropometric, hormonal and lipid profiles in polycystic ovarian syndrome.β2肾上腺素能受体多态性(rs1042713和rs1042714)对多囊卵巢综合征患者人体测量学指标、激素水平及血脂谱的影响。
J Med Biochem. 2021 Jan 26;40(1):74-85. doi: 10.5937/jomb0-26183.
5
GDF15/GFRAL Pathway as a Metabolic Signature for Cachexia in Patients with Cancer.GDF15/GFRAL通路作为癌症患者恶病质的代谢特征
J Cancer. 2021 Jan 1;12(4):1125-1132. doi: 10.7150/jca.50376. eCollection 2021.
6
Lipid profiles of persons with paraplegia and tetraplegia: sex differences.截瘫和四肢瘫患者的血脂谱:性别差异
J Spinal Cord Med. 2008;31(3):285-9. doi: 10.1080/10790268.2008.11760724.
7
Exercise metabolism and beta-blocker therapy. An update.运动代谢与β受体阻滞剂治疗。最新进展。
Sports Med. 1999 Feb;27(2):81-96. doi: 10.2165/00007256-199927020-00002.
8
Reduced ambulatory heart rate response to physical work and complaints of fatigue among hypertensive males treated with beta-blockers.接受β受体阻滞剂治疗的男性高血压患者静息心率对体力活动的反应降低及疲劳主诉
J Behav Med. 1995 Apr;18(2):113-26. doi: 10.1007/BF01857864.
9
Metabolic responses to beta 2 stimulants.对β2兴奋剂的代谢反应。
J R Coll Physicians Lond. 1984 Jul;18(3):190-4.
10
Beta-adrenoceptor blockade and exercise. An update.β-肾上腺素能受体阻滞剂与运动。最新进展。
Sports Med. 1988 Apr;5(4):209-25. doi: 10.2165/00007256-198805040-00002.